ABN – According to a study published in Nature, a new antimalarial compound may be capable of treating current infections while also protecting against future ones.
Only one dose of the compound is needed to fight malaria infections and increase the patients’ immunity against the parasite.
One of the leaders of the Study Kevin Read, a researcher at the University of Dundee, said: "The compound interferes with some of the machinery involved in protein synthesis in the parasite at different stages of its life cycle."
London School of Hygiene & Tropical Medicine head Colin Sutherland added: "The chemical compound of this potential drug is different from any other antimalarial compound in that it interacts at many different stages of the parasite life cycle.
"It is absolutely crucial that new compounds such as this one are coming through the pipeline.
"There is a lot of work to be done before this can be formulated into a usable drug - and it still may fail at some stage - but this initial preclinical work is very encouraging."
The compound, currently named DDD107498, stays active in the body for a very long time therefore protecting patients against any future infections.
It was discovered in 2010 but it is not expected to become available until at least 2020.